Status:
COMPLETED
Evaluation of a Symptom and Needs Assessment for Patients With Cancer
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a quality improvement study that aims to improve on the timely identification and management of symptoms and supportive care needs in patients with cancer. The study will be evaluating the rel...
Detailed Description
Cancer patients' under-identified symptoms and concerns can result in treatment interference, poor care satisfaction, compromised health-related quality of life, and taxed healthcare systems. Cancer c...
Eligibility Criteria
Inclusion
- Must have medical chart confirmed diagnosis of a solid or hematological malignancy
- Must have had oncology services at a Northwestern Medicine location within the past 12 months
- Must have completed the current symptom monitoring assessment offered by Northwestern Medicine
- Must be willing to complete electronic patient-reported measures (i.e. patient reported health care utilization and satisfaction surveys) at baseline, 6-month, and 12-month follow-up time points, and
- Must consent to give authorized study staff access to details of their cancer diagnosis and treatment as documented in their electronic health record
- If participating in a semi-structured interview or focus group, must consent to have their comments audio-recorded
- Exclusion Criteria:
- \-
Exclusion
Key Trial Info
Start Date :
July 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
1166 Patients enrolled
Trial Details
Trial ID
NCT04014751
Start Date
July 15 2019
End Date
May 31 2022
Last Update
January 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Medicine
Chicago, Illinois, United States, 60611